ArticleFrontiers in psychiatry2022
ADHD in the DSM-5-TR: What has changed and what has not.
Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial intelligence in ADHD: a global perspective on research hotspots, trends and clinical applications.Frontiers in human neuroscience · 2025Pooled it
- Age-Related Cognitive Patterns in Children With Attention-Deficit/Hyperactivity Disorder and Typically Developing Children: A Comparative Study.Journal of Korean medical science · 2026Article
- Incidence of ADHD diagnoses and medication initiation among children and adolescents in Norway from 2016-2024.European child & adolescent psychiatry · 2026Article
- Breaking down the ADHD construct to build a valid diagnosis.Acta neuropsychiatrica · 2026Review
- Mind the Gap! Sleep Problems in Children With ADHD-A Qualitative Analysis of Clinician Training Needs.Child: care, health and development · 2026Article
- Review
- Genetic insights into the effect of Metformin on psychiatry disorders.European archives of psychiatry and clinical neuroscience · 2025Article
- Development of a human analogue ADHD diagnostic system for family dogs.Scientific reports · 2025Article
- Machine learning based predictive model of the risk of Tourette syndrome with SHAP value interpretation: a retrospective observational study.Scientific reports · 2025Observational
- Gut-immune-brain interactions during neurodevelopment: from a brain-centric to a multisystem perspective.BMC medicine · 2025Review
- Where Is My Mind? The Daydreaming Characteristics Questionnaire, a New Tool to Differentiate Absorptive Daydreaming From Mind-Wandering.Journal of attention disorders · 2025Article
- Personality Traits in Adolescents with ADHD: Insights into Dimension Evaluation and Clinical Implications Using the Personality Inventory for the DSM-5 Questionnaire.Journal of clinical medicine · 2025Article
- Validity of the Italian Version of DIVA-5: Semi-Structured Diagnostic Interview for Adult ADHD Based on the DSM-5 Criteria.Healthcare (Basel, Switzerland) · 2025Article
- Machine Learning Based Early Diagnosis of ADHD with SHAP Value Interpretation: A Retrospective Observational Study.Neuropsychiatric disease and treatment · 2025Article
- Does age of ADHD medication initiation predict long-term risk of anxiety? A scoping review.PLOS mental health · 2025Article
- Expression Patterns of miRNAs in Egyptian Children with ADHD: Clinical Study with Correlation Analysis.Journal of molecular neuroscience : MN · 2024Article
- Comparison of self-esteem and quality of life in 8-12-year-old children with ADHD with and without learning disorders.BMC psychology · 2024Article
- Attention Deficit Hyperactivity Disorder Among Youth at Clinical High Risk of Psychosis.Schizophrenia bulletin open · 2024Article
- Behavior Rating Inventory of Executive Function in Preschool (BRIEF-P) and Attention-Deficit and Hyperactivity Disorders (ADHD): A Systematic Review and Meta-Analysis of Floor and Ceiling Effects.Children (Basel, Switzerland) · 2023Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this article, we critically review the changes made to the DSM-5 Text Revision published in 2022 regarding the diagnostic entity of Attention Deficit/Hyperactivity Disorder (ADHD). We structure our critique around three points. The first discusses the acknowledgment of ADHD as a neurodevelopmental disorder. The second examines the definition of ADHD provided in the updated edition of the manual. The third scrutinizes the changes in the diagnostic criteria for ADHD and assesses whether these changes make the diagnosis more accurate. We conclude that DSM's latest edition does not escape the logical and scientific pitfalls of its predecessor. DSM-5-TR keeps the faith in the neo-Kraepelinian paradigm by explicitly and implicitly cultivating the essentialist medical scientific metaphor of disorder, creating the illusion that it represents scientific progress that validates ADHD as a neurodevelopmental disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.